Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Utility of Quantification of Afferent Pupillary Defect in Predicting Optic Nerve Disease in Retrobulbar Neuritis, Multiple Sclerosis and Neuromyelitis Optica Spectrum Disease - a Retrospective and Prospective Analysis

NCT04131764 is registered in ClinicalTrials.gov with Jagannadha R Avasarala as lead sponsor.

NCT NCT04131764
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04131764 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Utility of Quantification of Afferent Pupillary Defect in Predicting Optic Nerve Disease in Retrobulbar Neuritis, Multiple Sclerosis and Neuromyelitis Optica Spectrum Disease - a Retrospective and Prospective Analysis
Lead sponsor
Jagannadha R Avasarala
Phase
Observational
Overall status
Terminated
Start date
October 4, 2019
Completion date
September 6, 2022
Enrollment
112 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis, neuromyelitis optica spectrum disorder attack, neuromyelitis optica spectrum disorder progression, neuromyelitis optica spectrum disorder relapse, optic neuritis